Stay updated on Durvalumab and Daratumumab in MM Clinical Trial
Sign up to get notified when there's something new on the Durvalumab and Daratumumab in MM Clinical Trial page.

Latest updates to the Durvalumab and Daratumumab in MM Clinical Trial page
- Check3 days agoChange DetectedPrimary disease term 'Multiple myeloma' and a related topics section were removed. This reduces direct disease context and eliminates some linked resources on the page.SummaryDifference0.1%

- Check10 days agoChange DetectedThe update adds 'Multiple myeloma' and related topics including MedlinePlus Genetics, and updates the site revision from v3.6.3 to v3.6.4.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page no longer includes the disease name 'Multiple myeloma' in the study description and removes the 'related topics:' header and the 'MedlinePlus Genetics' resource reference.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check32 days agoChange Detected- The related topics section now includes 'Multiple myeloma' and 'MedlinePlus Genetics', and the revision label shows v3.6.3 (replacing v3.6.2).SummaryDifference0.1%

- Check39 days agoChange DetectedRevision: v3.6.2 has been added to the page, and the older Revision: v3.6.0 has been removed. Related topics entries such as Multiple myeloma and MedlinePlus Genetics were removed from the related topics section.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page now displays a recruitment status note stating recruitment has ended, and adds new help/navigation sections such as How to Read a Study Record, Common Questions, and How to Join a Study, along with a formatting change to the Intervention/Treatment label. Additionally, the revision tag has been updated to Revision: v3.6.0, replacing the previous v3.5.5.SummaryDifference0.3%

Stay in the know with updates to Durvalumab and Daratumumab in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab and Daratumumab in MM Clinical Trial page.